Library.

“Cannabis lowers estrogen levels in women.”

Available evidence does not establish that cannabis lowers estrogen levels in women. Although preclinical research suggests cannabinoids could disrupt hormone-regulating pathways, direct human evidence is limited and has generally not shown a consistent reduction in estradiol. The claim turns a plausible mechanism into an unqualified causal effect that clinical research has not demonstrated.

“Low muscle mass does not impair estrogen production.”

Available evidence supports the practical conclusion that low muscle mass is not known to meaningfully reduce systemic estrogen production. Ovaries and adipose tissue are much more important estrogen sources, and research chiefly shows low estrogen contributing to muscle loss. Direct studies have not established that muscle loss has absolutely no effect, so the categorical wording is stronger than the evidence.

“Excessive dietary salt intake lowers estrogen levels in women.”

The evidence does not support the claim that excessive dietary salt intake lowers estrogen levels in women. The only direct human study cited found that changing sodium intake did not alter estrone or estradiol in postmenopausal women. Studies in this evidence set mainly show the opposite relationship: estrogen influences salt sensitivity and fluid balance, while animal findings suggesting hormonal changes with high salt do not establish the same effect in women.

“In women, lower estrogen levels are associated with increased fingernail hardness.”

Available evidence does not support this association. Sources consistently describe lower estrogen as contributing to reduced nail hydration and keratin support, leading to brittle, weaker, thinner, softer, and more breakable nails rather than harder ones. The claim relies on conflating fragility or rigidity from dryness with true hardness.

“A deficiency of estrogen (female sex hormones) can be a cause of underweight in people of any sex.”

The evidence does not support estrogen deficiency as a cause of underweight. In the stronger medical literature, low estrogen is more often linked to increased fat mass and weight gain, while underweight and calorie deficiency commonly cause low estrogen by suppressing reproductive hormone function. The claim reverses the usual direction of causation and overgeneralizes across sexes.

“Women with excessive muscle mass have reduced estrogen levels.”

The evidence does not support a general rule that muscular women have reduced estrogen levels. Most higher-quality research indicates estrogen helps preserve and build muscle in women, while low estrogen is more often linked to muscle loss or menopause-related decline. Cases where very lean or elite female athletes have low estrogen are usually explained by low energy availability, menstrual dysfunction, or other confounders rather than muscle mass itself.

“Excessive muscle mass in men causes estrogen deficiency.”

The evidence does not support the idea that excessive muscle mass in men causes estrogen deficiency. In men, low estrogen is usually linked to low testosterone, impaired aromatization, certain drugs, or endocrine disease—not to having a lot of muscle. Several credible sources point in the opposite direction or find no such causal relationship.

“In men, having low muscle mass causes estrogen levels to become abnormally high.”

The evidence does not support low muscle mass as a cause of abnormally high estrogen in men. Higher estradiol is more consistently associated with increased fat mass and aromatization, while studies often find weak, inconsistent, or no independent link between estradiol and muscle mass. The claim confuses low muscle with high body fat and overstates both causation and hormone abnormality.

“Excessive sugar intake lowers estrogen levels in women.”

The evidence does not support the claim that excessive sugar lowers estrogen levels in women. The strongest human studies cited point the other way, linking higher sugar intake with higher estradiol or lower SHBG, which can increase bioavailable estrogen. Animal and cell studies describe altered hormone regulation or estrogen action, but they do not establish that sugar lowers circulating estrogen in women.

“In men, having an excessive amount of body fat causes estrogen levels to become abnormally high.”

Excess body fat in men commonly raises estrogen production through increased aromatase activity, and many studies find higher estradiol or related estrogens in obese men. However, the effect is not universal, and serum estradiol is not always clearly or clinically abnormal in every study or every man. The claim is directionally accurate but stronger than the evidence warrants.

“Obesity in women causes estrogen deficiency.”

The evidence does not support the broad claim as stated. In some premenopausal contexts, obesity is associated with lower estradiol or altered hormone signaling, but after menopause obesity commonly raises estrogen levels because adipose tissue produces estrogen. That means the relationship is bidirectional and depends heavily on menopausal status, so describing obesity in women generally as causing estrogen deficiency is materially misleading.

“Women with insufficient body fat have reduced estrogen levels.”

The evidence strongly supports a real physiological link. Very low body fat is associated with lower estrogen because adipose tissue helps produce estrogen and because low fat often accompanies low energy availability, which can suppress ovarian hormone production. The main caveat is that there is no single body-fat percentage that defines "insufficient" for every woman.

“Being underweight in males causes excess estrogen levels.”

The evidence does not support underweight status as a cause of excess estrogen in males. Medical literature consistently links higher body fat—not low body weight—to higher estradiol because adipose tissue increases aromatization. In men, being underweight is more often associated with lower estrogen levels or broader hormonal suppression, not estrogen excess.

“In women, lower levels of estrogen are associated with faster toenail growth.”

The available evidence points in the opposite direction. Sources discussing menopause and nail biology associate lower estrogen with slower nail growth and increased brittleness, while higher-estrogen states are described as linked to faster growth. The main quantitative toenail-growth study provides no estrogen association, so the claim is not supported as stated.

“Having greater muscle mass makes it easier for the body to eliminate estrogen.”

The evidence does not support muscle mass as a meaningful driver of estrogen elimination. Estrogen is cleared mainly through liver metabolism and biliary/renal excretion, while muscle-related studies describe local hormone activity within muscle rather than whole-body clearance. Exercise can be associated with lower estrogen in some contexts, but that is more consistently tied to reduced fat mass than to having more muscle.